Bioventus Inc.BVSNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
5Y CAGR+21.9%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

5Y CAGR
+21.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$57.06M+576.4%
2024$-11.98M+85.3%
2023$-81.72M+51.1%
2022$-167.23M-1486.6%
2021$12.06M-43.2%
2020$21.24M-31.9%
2019$31.19M+22.3%
2018$25.50M-5.6%
2017$27.02M+81.5%
2016$14.89M-